Letter

Ethnic differences in risks of adverse reactions: Is personalised drug treatment better with pharmacokinetic modelling?

BMJ 2006; 332 doi: 10.1136/bmj.332.7554.1393 (Published 8 June 2006)
Cite this as: BMJ 2006;332:1393.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. David S Millson (david.millson@tiscali.co.uk), general practitioner principal
  1. Leek Health Centre, Leek ST13 6JB

    EDITOR—McDowell et al conclude that patients from different ethnic groups have different risks for important adverse drug reactions on the basis of a meta-analysis of adverse reactions due to drugs used in cardiovascular medicine.1 Data are sparse, and regulators should ask for better …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular